BRISTOL-MYERS SQUIBB FARMACÊUTICA LTDA
Mudanças na lista de 09/10/2026
sem mudanças
| Produto | Apresentação | Substância | PF 0 % | PMC 0 % | PMVG 0 % | Regime |
|---|---|---|---|---|---|---|
| CAMZYOS | 10 MG CAP DURA CT BL AL PLAS PVC/PCTFE TRANS X 28 | MAVACANTENO | R$ 7.952,68 | R$ 10.668,24 | R$ 6.378,84 | Regulado |
| CAMZYOS | 15 MG CAP DURA CT BL AL PLAS PVC/PCTFE TRANS X 28 | MAVACANTENO | R$ 7.952,68 | R$ 10.668,24 | R$ 6.378,84 | Regulado |
| CAMZYOS | 2,5 MG CAP DURA CT BL AL PLAS PVC/PCTFE TRANS X 28 | MAVACANTENO | R$ 7.952,68 | R$ 10.668,24 | R$ 6.378,84 | Regulado |
| CAMZYOS | 5 MG CAP DURA CT BL AL PLAS PVC/PCTFE TRANS X 28 | MAVACANTENO | R$ 7.952,68 | R$ 10.668,24 | R$ 6.378,84 | Regulado |
| EMPLICITI | 300 MG PO LIOF SOL INJ CT 1 FA VD TRANS | ELOTUZUMABE | R$ 7.611,16 | – | R$ 6.104,91 | Regulado |
| EMPLICITI | 400 MG PO LIOF SOL INJ CT 1 FA VD TRANS | ELOTUZUMABE | R$ 10.148,19 | – | R$ 8.139,86 | Regulado |
| IMREVITE | 100 MG SOL INJ CT 1 FA VD INC X 10 ML | NIVOLUMABE | R$ 9.392,06 | – | R$ 7.533,37 | Regulado |
| IMREVITE | 40 MG SOL INJ CT 1 FA VD INC X 4 ML | NIVOLUMABE | R$ 3.756,84 | – | R$ 3.013,36 | Regulado |
| IMREVITE | 600 MG SOL INJ SC CT FA VD TRANS X 5 ML | NIVOLUMABE | R$ 22.540,94 | – | R$ 18.080,09 | Regulado |
| NIVDIREC | 100 MG SOL INJ CT 1 FA VD INC X 10 ML | NIVOLUMABE | R$ 9.392,06 | – | R$ 7.533,37 | Regulado |
| NIVDIREC | 40 MG SOL INJ CT 1 FA VD INC X 4 ML | NIVOLUMABE | R$ 3.756,84 | – | R$ 3.013,36 | Regulado |
| NIVDIREC | 600 MG SOL INJ SC CT FA VD TRANS X 5 ML | NIVOLUMABE | R$ 22.540,94 | – | R$ 18.080,09 | Regulado |
| OPDIVO | 100 MG SOL INJ CT 1 FA VD INC X 10 ML | NIVOLUMABE | R$ 9.392,06 | – | R$ 7.533,37 | Regulado |
| OPDIVO | 40 MG SOL INJ CT 1 FA VD INC X 4 ML | NIVOLUMABE | R$ 3.756,84 | – | R$ 3.013,36 | Regulado |
| OPDIVO | 600 MG SOL INJ SC CT FA VD TRANS X 5 ML | NIVOLUMABE | R$ 22.540,94 | – | R$ 18.080,09 | Regulado |
| OPDUALAG | 12 MG/ML + 4 MG/ML SOL INJ CT 1 FA VD TRANS X 20 ML | NIVOLUMABE;RELATLIMABE | R$ 31.520,73 | – | R$ 25.282,78 | Regulado |
| ORENCIA | 125 MG/ML SOL INJ SC CT 4 SER PREENC VD TRANS + DISPOSITIVO ULTRASAFE PASSIVE + EXTENSORES DE APOIO | ABATACEPTE | R$ 6.743,91 | R$ 9.295,78 | R$ 5.409,29 | Regulado |
| ORENCIA | 250 MG PO LIOF SOL INJ CT 1 FA + SER DESCARTÁVEL | ABATACEPTE | R$ 2.123,68 | – | R$ 1.703,40 | Regulado |
| POMALYST | 1 MG CAP DURA CT BL AL PLAS PVC/PCTFE TRANS X 14 | POMALIDOMIDA | R$ 7.840,28 | R$ 10.517,46 | R$ 6.288,69 | Regulado |
| POMALYST | 1 MG CAP DURA CT BL AL PLAS PVC/PCTFE TRANS X 21 | POMALIDOMIDA | R$ 11.760,42 | R$ 15.776,18 | R$ 9.433,03 | Regulado |
| POMALYST | 2 MG CAP DURA CT BL AL PLAS PVC/PCTFE TRANS X 14 | POMALIDOMIDA | R$ 8.554,32 | R$ 11.475,32 | R$ 6.861,42 | Regulado |
| POMALYST | 2 MG CAP DURA CT BL AL PLAS PVC/PCTFE TRANS X 21 | POMALIDOMIDA | R$ 12.831,49 | R$ 17.212,99 | R$ 10.292,14 | Regulado |
| POMALYST | 3 MG CAP DURA CT BL AL PLAS PVC/PCTFE TRANS X 14 | POMALIDOMIDA | R$ 8.554,32 | R$ 11.475,32 | R$ 6.861,42 | Regulado |
| POMALYST | 3 MG CAP DURA CT BL AL PLAS PVC/PCTFE TRANS X 21 | POMALIDOMIDA | R$ 12.831,49 | R$ 17.212,99 | R$ 10.292,14 | Regulado |
| POMALYST | 4 MG CAP DURA CT BL AL PLAS PVC/PCTFE TRANS X 14 | POMALIDOMIDA | R$ 11.009,37 | R$ 14.768,68 | R$ 8.830,62 | Regulado |
| POMALYST | 4 MG CAP DURA CT BL AL PLAS PVC/PCTFE TRANS X 21 | POMALIDOMIDA | R$ 17.108,61 | R$ 22.950,59 | R$ 13.722,82 | Regulado |
| REBLOZYL | 25 MG PO LIOF SOL INJ SC CT FA VD TRANS | LUSPATERCEPTE | R$ 12.841,00 | – | R$ 10.299,77 | Regulado |
| REBLOZYL | 75 MG PO LIOF SOL INJ SC CT FA VD TRANS | LUSPATERCEPTE | R$ 38.518,67 | – | R$ 30.895,83 | Regulado |
| REVLIMID | 10 MG CAP DURA CT BL AL PLAS TRANS X 21 | LENALIDOMIDA | R$ 19.508,47 | R$ 26.169,92 | R$ 15.647,74 | Regulado |
| REVLIMID | 10 MG CAP DURA CT BL AL PLAS TRANS X 28 | LENALIDOMIDA | R$ 24.931,79 | R$ 33.445,11 | R$ 19.997,79 | Regulado |
| REVLIMID | 15 MG CAP DURA CT BL AL PLAS TRANS X 21 | LENALIDOMIDA | R$ 20.577,46 | R$ 27.603,93 | R$ 16.505,18 | Regulado |
| REVLIMID | 15 MG CAP DURA CT BL AL PLAS TRANS X 28 | LENALIDOMIDA | R$ 26.297,91 | R$ 35.277,71 | R$ 21.093,55 | Regulado |
| REVLIMID | 20 MG CAP DURA CT BL AL PLAS TRANS X 21 | LENALIDOMIDA | R$ 22.635,27 | R$ 30.364,41 | R$ 18.155,75 | Regulado |
| REVLIMID | 25 MG CAP DURA CT BL AL PLAS TRANS X 14 | LENALIDOMIDA | R$ 16.094,41 | R$ 21.590,08 | R$ 12.909,33 | Regulado |
| REVLIMID | 25 MG CAP DURA CT BL AL PLAS TRANS X 21 | LENALIDOMIDA | R$ 22.635,27 | R$ 30.364,41 | R$ 18.155,75 | Regulado |
| REVLIMID | 5 MG CAP DURA CT BL AL PLAS TRANS X 21 | LENALIDOMIDA | R$ 18.606,47 | R$ 24.959,92 | R$ 14.924,25 | Regulado |
| ROJUZDA | 25 MG PO LIOF SOL INJ SC CT FA VD TRANS | LUSPATERCEPTE | R$ 12.840,99 | – | R$ 10.299,76 | Regulado |
| ROJUZDA | 75 MG PO LIOF SOL INJ SC CT FA VD TRANS | LUSPATERCEPTE | R$ 38.518,66 | – | R$ 30.895,82 | Regulado |
| SOTYKTU | 6 MG COM REV CT BL AL PLAS PVC/PCTFE TRANS X 28 | DEUCRAVACITINIBE | R$ 3.481,42 | R$ 4.670,20 | R$ 2.792,45 | Regulado |
| SPRYCEL | 100 MG COM REV CT FR PLAS PEAD OPC X 30 | DASATINIBE MONOIDRATADO | R$ 15.001,94 | R$ 20.678,61 | R$ 12.033,06 | Regulado |
| SPRYCEL | 20 MG COM REV CT FR PLAS PEAD OPC X 60 | DASATINIBE | R$ 7.554,32 | R$ 10.412,84 | R$ 6.059,32 | Regulado |
| YERVOY | 50 MG SOL INJ CT 1 FA VD TRANS X 10 ML | IPILIMUMABE | R$ 20.629,76 | – | R$ 16.547,13 | Regulado |